Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports Posted by Teresa Lynn in biotech/medical Oct 12021 The drug, molnupiravir, could be the first oral antiviral medication for covid-19. Read more | >
